Endorsed by the American Society for Preventive Cardiology! This Companion to Braunwald’s Heart Disease addresses prevention and risk stratification of cardiovascular disease to delay onset of disease and moderate its effects and complications. The authors discuss a range of topics including risk assessment, multiple risk-factor prevention strategies, and developments in genetics and personalized medicine. This text provides the clinically relevant details needed to effectively prevent cardiovascular disease.
1. Cover image - p. Cover 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iii 5. Dedication - p. iii 6. Contributors - p. iii 7. Foreword - p. iii 8. Preface - p. iii 9. Look for These Other Titles in the Braunwald’s Heart Disease Family - p. iii 10. Updates to the Book - p. iii 11. Section I: Assessment of Risk - p. iii 12. Chapter 1: Preventive Cardiology: Past, Present, and Future - p. iii 13. Chapter 2: National and International Trends in Cardiovascular Disease: Incidence and Risk Factors - p. iii 14. Chapter 3: Prediction of Cardiovascular Disease: Framingham Risk Estimation and Beyond - p. g0015 15. Chapter 4: Genetics of Cardiovascular Disease and Its Role in Risk Prediction - p. g0015 16. Chapter 5: Novel Biomarkers and the Assessment of Cardiovascular Risk - p. g0015 17. Chapter 6: Advanced Risk Assessment in Patients with Kidney and Inflammatory Diseases - p. g0015 18. Section II: Atherothrombosis and Antiplatelet Therapy - p. g0015 19. Chapter 7: Antiplatelet Therapy - p. g0015 20. Chapter 8: Molecular Biology and Genetics of Atherosclerosis - p. g0015 21. Section III: Blood Pressure - p. g0015 22. Chapter 9: Hypertension: JNC 7 and Beyond - p. g0015 23. Chapter 10: Heart Failure Prevention - p. g0015 24. Chapter 11: Antihypertensive Drugs and Their Cardioprotective and Renoprotective Roles in the Prevention and Management of Cardiovascular Disease - p. g0015 25. Section IV: Cholesterol/Dyslipidemia - p. g0015 26. Chapter 12: Evaluation and Management of Dyslipidemia in Children and Adolescents - p. g0015 27. Chapter 13: The Role of High-Density Lipoprotein Cholesterol in the Development of Atherosclerotic Cardiovascular Disease - p. g0015 28. Chapter 14: Low-Density Lipoprotein Cholesterol: Role in Atherosclerosis and Approaches to Therapeutic Management - p. g0015 29. Chapter 15: The Contribution of Triglycerides and Triglyceride-Rich Lipoproteins to Atherosclerotic Cardiovascular Disease - p. g0015 30. Section V: Diet and Lifestyle Factors - p. g0015 31. Chapter 16: Nutritional Approaches for Cardiovascular Disease Prevention - p. g0015 32. Chapter 17: Integrative Medicine in the Prevention of Cardiovascular Disease - p. g0015 33. Chapter 18: Effects of Alcohol on Cardiovascular Disease Risk - p. g0015 34. Chapter 19: Overweight, Obesity, and Cardiovascular Risk - p. g0015 35. Chapter 20: Tobacco Use, Passive Smoking, and Cardiovascular Disease: Research and Smoking Cessation Interventions - p. g0015 36. Section VI: Diabetes Mellitus - p. g0015 37. Chapter 21: Diabetes and Cardiovascular Disease - p. g0015 38. Chapter 22: Metabolic Syndrome and Cardiovascular Disease - p. g0015 39. Section VII: Special Populations - p. g0015 40. Chapter 23: Role of Ethnicity in Cardiovascular Disease: Lessons Learned from MESA and Other Population-Based Studies - p. g0015 41. Chapter 24: Prevention of Ischemic Heart Disease in Women - p. g0015 42. Chapter 25: Cardiovascular Aging: The Next Frontier in Cardiovascular Prevention - p. g0015 43. Section VIII: Diagnostic Testing to Help Improve Risk Prediction - p. g0015 44. Chapter 26: Concepts of Screening for Cardiovascular Risk Factors and Disease - p. g0015 45. Chapter 27: Role of Vascular Computed Tomography in Evaluation and Prevention of Cardiovascular Disease - p. g0015 46. Chapter 28: Use of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography in Assessment of Cardiovascular Disease Risk and Atherosclerosis Progression - p. g0015 47. Chapter 29: Exercise Treadmill Stress Testing With and Without Imaging - p. g0015 48. Chapter 30: Carotid Intima-Media Thickness Measurement and Plaque Detection for Cardiovascular Disease Risk Prediction - p. g0015 49. Chapter 31: Peripheral Arterial Disease Assessment and Management - p. g0015 50. Chapter 32: Endothelial Function and Dysfunction - p. g0015 51. Section IX: Exercise/Emotional Aspects of Preventive Cardiology - p. g0015 52. Chapter 33: Exercise for Restoring Health and Preventing Vascular Disease - p. g0015 53. Chapter 34: Psychological Risk Factors and Coronary Artery Disease: Epidemiology, Pathophysiology, and Management - p. g0015 54. Chapter 35: The Role of Treatment Adherence in Cardiac Risk Factor Modification - p. g0015 55. Chapter 36: Clinical Practice Guidelines and Performance Measures in the Treatment of Cardiovascular Disease - p. g0015 56. Index - p. g0015
Endorsed by the American Society for Preventive Cardiology! This Companion to Braunwald’s Heart Disease addresses prevention and risk stratification of cardiovascular disease to delay onset of disease and moderate its effects and complications. The authors discuss a range of topics including risk assessment, multiple risk-factor prevention strategies, and developments in genetics and personalized medicine. This text provides the clinically relevant details needed to effectively prevent cardiovascular disease.
1. Cover image - p. Cover 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iii 5. Dedication - p. iii 6. Contributors - p. iii 7. Foreword - p. iii 8. Preface - p. iii 9. Look for These Other Titles in the Braunwald’s Heart Disease Family - p. iii 10. Updates to the Book - p. iii 11. Section I: Assessment of Risk - p. iii 12. Chapter 1: Preventive Cardiology: Past, Present, and Future - p. iii 13. Chapter 2: National and International Trends in Cardiovascular Disease: Incidence and Risk Factors - p. iii 14. Chapter 3: Prediction of Cardiovascular Disease: Framingham Risk Estimation and Beyond - p. g0015 15. Chapter 4: Genetics of Cardiovascular Disease and Its Role in Risk Prediction - p. g0015 16. Chapter 5: Novel Biomarkers and the Assessment of Cardiovascular Risk - p. g0015 17. Chapter 6: Advanced Risk Assessment in Patients with Kidney and Inflammatory Diseases - p. g0015 18. Section II: Atherothrombosis and Antiplatelet Therapy - p. g0015 19. Chapter 7: Antiplatelet Therapy - p. g0015 20. Chapter 8: Molecular Biology and Genetics of Atherosclerosis - p. g0015 21. Section III: Blood Pressure - p. g0015 22. Chapter 9: Hypertension: JNC 7 and Beyond - p. g0015 23. Chapter 10: Heart Failure Prevention - p. g0015 24. Chapter 11: Antihypertensive Drugs and Their Cardioprotective and Renoprotective Roles in the Prevention and Management of Cardiovascular Disease - p. g0015 25. Section IV: Cholesterol/Dyslipidemia - p. g0015 26. Chapter 12: Evaluation and Management of Dyslipidemia in Children and Adolescents - p. g0015 27. Chapter 13: The Role of High-Density Lipoprotein Cholesterol in the Development of Atherosclerotic Cardiovascular Disease - p. g0015 28. Chapter 14: Low-Density Lipoprotein Cholesterol: Role in Atherosclerosis and Approaches to Therapeutic Management - p. g0015 29. Chapter 15: The Contribution of Triglycerides and Triglyceride-Rich Lipoproteins to Atherosclerotic Cardiovascular Disease - p. g0015 30. Section V: Diet and Lifestyle Factors - p. g0015 31. Chapter 16: Nutritional Approaches for Cardiovascular Disease Prevention - p. g0015 32. Chapter 17: Integrative Medicine in the Prevention of Cardiovascular Disease - p. g0015 33. Chapter 18: Effects of Alcohol on Cardiovascular Disease Risk - p. g0015 34. Chapter 19: Overweight, Obesity, and Cardiovascular Risk - p. g0015 35. Chapter 20: Tobacco Use, Passive Smoking, and Cardiovascular Disease: Research and Smoking Cessation Interventions - p. g0015 36. Section VI: Diabetes Mellitus - p. g0015 37. Chapter 21: Diabetes and Cardiovascular Disease - p. g0015 38. Chapter 22: Metabolic Syndrome and Cardiovascular Disease - p. g0015 39. Section VII: Special Populations - p. g0015 40. Chapter 23: Role of Ethnicity in Cardiovascular Disease: Lessons Learned from MESA and Other Population-Based Studies - p. g0015 41. Chapter 24: Prevention of Ischemic Heart Disease in Women - p. g0015 42. Chapter 25: Cardiovascular Aging: The Next Frontier in Cardiovascular Prevention - p. g0015 43. Section VIII: Diagnostic Testing to Help Improve Risk Prediction - p. g0015 44. Chapter 26: Concepts of Screening for Cardiovascular Risk Factors and Disease - p. g0015 45. Chapter 27: Role of Vascular Computed Tomography in Evaluation and Prevention of Cardiovascular Disease - p. g0015 46. Chapter 28: Use of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography in Assessment of Cardiovascular Disease Risk and Atherosclerosis Progression - p. g0015 47. Chapter 29: Exercise Treadmill Stress Testing With and Without Imaging - p. g0015 48. Chapter 30: Carotid Intima-Media Thickness Measurement and Plaque Detection for Cardiovascular Disease Risk Prediction - p. g0015 49. Chapter 31: Peripheral Arterial Disease Assessment and Management - p. g0015 50. Chapter 32: Endothelial Function and Dysfunction - p. g0015 51. Section IX: Exercise/Emotional Aspects of Preventive Cardiology - p. g0015 52. Chapter 33: Exercise for Restoring Health and Preventing Vascular Disease - p. g0015 53. Chapter 34: Psychological Risk Factors and Coronary Artery Disease: Epidemiology, Pathophysiology, and Management - p. g0015 54. Chapter 35: The Role of Treatment Adherence in Cardiac Risk Factor Modification - p. g0015 55. Chapter 36: Clinical Practice Guidelines and Performance Measures in the Treatment of Cardiovascular Disease - p. g0015 56. Index - p. g0015
